New Key Statistics Module, Z-Score and F-Score
NAS:SNDX Key Ratios
Market Cap $ M | 1,115.63 |
Enterprise Value $ M | 710.08 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.04 |
Price/Sales | 69.89 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 16.00 |
EPS (TTM) $ | -3.63 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.46 |
EV-to-EBITDA | -2.46 |
PEG | -- |
Shares Outstanding M | 85.36 |
Net Margin (%) | -1,856.64 |
Operating Margin % | -2,007.58 |
Pre-tax Margin (%) | -1,856.64 |
Quick Ratio | 6.99 |
Current Ratio | 6.99 |
ROA % (ttm) | -60.43 |
ROE % (ttm) | -67.33 |
ROIC % (ttm) | -690.96 |
Dividend Yield % | -- |
Altman Z-Score | 6.31 |
SNDX Number of Guru Trades
SNDX Volume of Guru Trades
Gurus Latest Trades with NAS:SNDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SNDX is held by these investors
Total 1
Syndax Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SNDX
Total 0- 1